603387: Getein Biotech, Inc - Summary | Jitta

Getein Biotech, Inc

CHN:603387

Price
CN¥7.95
Loss Chance
47.5%
5.85JITTA SCORE
118.76%Over Jitta Line
Jitta Ranking
100 / 486
1,049 / 5,271
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (73)
Financial Strength (94)
Return to Shareholders (33)
Competitive Advantage (42)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 4.86% in the last year
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.85
118.76%
3.55
756.90%
4.23
> 1,000%
Biotechnology
5.62
133.48%
7.60
12.97%
5.79
135.02%
COMPANY DESCRIPTION
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.